The use of antithrombin in the treatment of pre-eclampsia

• 1. 先兆子痫胎盘间充质干细胞条件培养基用于在肿瘤治疗中的应用 [P] . 中国专利： CN104822385B . 2019.10.01
• 2. 先兆子痫胎盘间充质干细胞条件培养基用于在肿瘤治疗中的应用 [P] . 中国专利： CN104822385A . 2015-08-05
• 3. THE USE OF ANTITHROMBIN IN THE TREATMENT OF PRE-ECLAMPSIA [P] . 欧洲知识产权局专利： EP2825194A1 . 2015-01-21

  机译： 抗凝血酶在治疗先发性癫痫中的用途

• 4. THE USE OF ANTITHROMBIN IN THE TREATMENT OF PRE-ECLAMPSIA [P] . 欧洲知识产权局专利： EP2825194A4 . 2015-10-21

  机译： 抗凝血酶在治疗先发性癫痫中的用途

• 5. Use of antithrombin in the treatment of pre-eclampsia [P] . 日本专利： JP2015509984A . 2015-04-02

  机译： 抗凝血酶在先兆子痫的治疗中的应用

• 1. Polyguluronate Sulfate, Polymannuronate Sulfate, and Their Oligosaccharides Have Antithrombin Ⅲ-and Heparin Cofactor Ⅱ-independent Anticoagulant Activity [J] . ZENG Xuan, LAN Ying, ZENG Pengjiao, 中国海洋大学学报（英文版） . 2017,第002期
• 2. Antithrombin gene Arg197Stop mutation-associated venous sinus thrombosis in a Chinese family [J] . Ang Li, Dexin Wang, Qiming Xue, 中国神经再生研究（英文版） . 2011,第020期
• 3. Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report [J] . A Giarratano, G Cuccio, S Mangione Critical care : . 2000,第Suppla1期
• 4. Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia [J] . SpieziaL., VisentinS., RaduC., The journal of maternal-fetal & neonatal medicine . 2013,第13a14期
• 5. Plasmapheresis for the Treatment of Iatrogenic Antithrombin Excess as a Result of Spuriously Low Antithrombin Activity Measurements [J] . Reza Zarinshenas, Eric D. Destrampe, William Nicholas Rose Case Reports in Critical Care . 2020,第1期
• 6. Polyurethane Modified with an Antithrombin-Heparin Complex (ATH) via PEO: Effect of PEO End Group on ATH Immobilization and Subsequent Antithrombin and Fibrinogen Binding [C] . Kvla N. Sask, Leslie R. Berry, Anthony K. C. Chan, Annual meeting of the Society for Biomaterials . 2011
• 7. Thrombosis reduction by mass transport-enhanced recombinant antithrombin III. [D] . Leng, Bing. 2009
• 8. Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report [O] . A Giarratano, G Cuccio, S Mangione 2000
• 9. Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report [O] . Giarratano, A, Cuccio, G, Mangione, S 2000

• 1. Antithrombin in the treatment of burn trauma [J] . Areta Kowal-Vern1 ,Bruce A Orkin1 . 世界重症医学杂志 . 2016,第001期
• 2. Pharmacokinetic and Pharmacodynamic Properties of Batifiban Coadministered with Antithrombin Agents in Chinese Healthy Volunteers [J] . Xiao-meng HE ,Ying ZHOU ,Jie LI . 华中科技大学学报（医学）（英德文版） . 2013,第005期
• 3. Antithrombin Ⅲ injection via the portal vein suppresses liver damage [J] . Masayuki Miyazaki ,Masaki Kato ,Masatake Tanaka . 世界胃肠病学杂志：英文版 . 2012,第16期
• 4. 先兆子痫患者围术期治疗新进展 [C] . 刘毅 ,邓小明 . 第七次全国麻醉学与复苏进展学术会议 . 2009
• 5. 先兆子痫模型的建立与MDSC在先兆子痫中的作用及机制初探 [A] . 闫妍 . 2016